Beta Bionics (BBNX) Total Current Liabilities (2023 - 2026)

Beta Bionics has disclosed Total Current Liabilities across 4 years of filings, most recently posting $23.2 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $23.2 million, up 40.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.2 million (up 40.62% YoY), and the FY2025 annual result was $30.9 million, up 46.23% from the prior year.
• Total Current Liabilities came in at $23.2 million for Q1 2026 at Beta Bionics, down from $30.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $30.9 million in Q4 2025 to a low of $10.6 million in Q4 2023.
• The 4-year median for Total Current Liabilities is $21.1 million (2024), against an average of $21.0 million.
• Across the five-year window, Total Current Liabilities soared 99.42% in 2024 and soared 40.62% in 2026, its largest moves.
• Beta Bionics' Total Current Liabilities stood at $10.6 million in 2023, then jumped by 99.42% to $21.1 million in 2024, then soared by 46.23% to $30.9 million in 2025, then slipped by 25.01% to $23.2 million in 2026.
• The last three Total Current Liabilities figures came in at $23.2 million (Q1 2026), $30.9 million (Q4 2025), and $25.4 million (Q3 2025), per Business Quant data.